All content on this site is intended for healthcare professionals only. By acknowledging this message and accessing the information on this website you are confirming that you are a healthcare professional.
During the 31st European Academy of Dermatology and Venereology (EADV) Congress, the Psoriasis and Psoriatic Arthritis Hub was pleased to speak to Christine Bundy, Cardiff University, Cardiff, UK. We asked, What should shared decision-making look like in the management of psoriasis and psoriatic arthritis?
Bundy begins by outlining the positive trend between health outcomes and patient involvement, and then goes through the three stages of achieving shared decision-making and the importance of providing choices between balanced treatment options.
To finish, Bundy notes the need for specific research on the impact shared decision-making has on adherence in psoriasis and psoriatic arthritis.
What should shared decision-making look like in the management of psoriasis and psoriatic arthritis?
During the latest steering committee meeting, key opinion leaders met to discuss differential diagnosis and the importance of early treatment in psoriasis and psoriatic...
The SELECT-PsA 2 trial (NCT03104374) investigated the effect of upadacitinib compared with...
Subscribe to get the best content related to Psoriasis and Psoriatic Arthritis delivered to your inbox